Market Research Logo

REVA Medical Inc (RVA) - Product Pipeline Analysis, 2018 Update

Summary

REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold is designed to provide acute benefits as permanent drug-eluting metal stents. It also develops proprietary polymers for scaffold performance. The company's polymer also serves as the drug-delivery coating on fantom. It operates in Australia, Brazil and New Zealand, among others. REVA is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. 0
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company REVA Medical Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


REVA Medical Inc Company Overview
REVA Medical Inc Company Snapshot
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
REVA Medical Inc – Pipeline Analysis Overview
REVA Medical Inc - Key Facts
REVA Medical Inc - Major Products and Services
REVA Medical Inc Pipeline Products by Development Stage
REVA Medical Inc Ongoing Clinical Trials by Trial Status
REVA Medical Inc Pipeline Products Overview
Fantom Encore - 3.0 mm
Fantom Encore - 3.0 mm Product Overview
Fantom Encore - 3.5 mm
Fantom Encore - 3.5 mm Product Overview
Fantom Encore - Broader Matrix
Fantom Encore - Broader Matrix Product Overview
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Clinical Trial
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version Product Overview
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold Product Overview
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold Product Overview
REVA Medical Inc - Key Competitors
REVA Medical Inc - Key Employees
REVA Medical Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
REVA Medical Inc, Recent Developments
May 24, 2018: Reva Symposium Showcases Clinical Data
May 23, 2018: Fantom’s Positive Two-Year Results Show Sustained Safety and Efficacy
May 16, 2018: Reva Announces First Implant Of The Fantom Bioresorbable Scaffold In Turkey
May 09, 2018: Reva Medical Announces First Quarter 2018 Financial Results
Apr 16, 2018: REVA to Present Full Two-Year FANTOM II Data at EuroPCR
Apr 02, 2018: REVA Initiates Commercial Distribution Partnership in Turkey
Mar 27, 2018: REVA Announces First Implant of the Fantom Encore Bioresorbable Scaffold in Switzerland
Mar 08, 2018: REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results
Feb 26, 2018: Multicenter Study Suggests Hill-Rom MetaNeb System Reduces Incidence of Post-Operative Pulmonary Complications in High-Risk Patients
Feb 26, 2018: Reva Announces CE Mark And First Implant Of The Fantom Encore Bioresorbable Scaffold
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
REVA Medical Inc Pipeline Products by Equipment Type
REVA Medical Inc Pipeline Products by Indication
REVA Medical Inc Ongoing Clinical Trials by Trial Status
REVA Medical Inc, Key Facts
REVA Medical Inc, Major Products and Services
REVA Medical Inc Number of Pipeline Products by Development Stage
REVA Medical Inc Pipeline Products Summary by Development Stage
REVA Medical Inc Ongoing Clinical Trials by Trial Status
REVA Medical Inc Ongoing Clinical Trials Summary
Fantom Encore - 3.0 mm - Product Status
Fantom Encore - 3.0 mm - Product Description
Fantom Encore - 3.5 mm - Product Status
Fantom Encore - 3.5 mm - Product Description
Fantom Encore - Broader Matrix - Product Status
Fantom Encore - Broader Matrix - Product Description
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Status
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Thinner Version - Product Description
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Status
Fantom Sirolimus-Eluting Bioresorbable Peripheral Scaffold - Product Description
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description
REVA Medical Inc, Key Employees
REVA Medical Inc, Subsidiaries
Glossary
List of Figures
REVA Medical Inc Pipeline Products by Equipment Type
REVA Medical Inc Pipeline Products by Development Stage
REVA Medical Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report